Zai Lab (ZLAB) Profit After Tax (2018 - 2026)
Zai Lab (ZLAB) posted quarterly Profit After Tax of -$51.0 million for Q1 2026, down 5.32% year-on-year from -$53.9 million in Q1 2025, and down 1.2% on a QoQ basis from -$50.4 million in Q4 2025.
Zai Lab (ZLAB) Profit After Tax (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Profit After Tax for 9 consecutive years, with -$51.0 million the latest figure, recorded in Q1 2026.
- Quarterly Profit After Tax fell 5.32% year-over-year to -$51.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$178.1 million (up 29.34% YoY) and the FY2025 annual result came in at -$175.5 million, up 31.73% from the prior year.
- Profit After Tax declined to -$51.0 million in Q1 2026 per ZLAB's latest filing, from -$50.4 million in the prior quarter.
- Over the last five years, Profit After Tax for ZLAB reached as high as -$36.0 million in Q3 2025 and fell as low as -$161.2 million in Q3 2022.
- A 5-year average of -$74.2 million and a median of -$61.8 million in 2022 frame the typical range for Profit After Tax.
- The largest YoY upside for Profit After Tax was 70.84% in 2022 against a maximum downside of 67.19% in 2022.
- Year by year, Profit After Tax stood at -$61.8 million in 2022, then sank by 54.49% to -$95.4 million in 2023, then advanced by 14.4% to -$81.7 million in 2024, then surged by 38.29% to -$50.4 million in 2025, then decreased by 1.2% to -$51.0 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$51.0 million, -$50.4 million, and -$36.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | -51.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.02 Mn |
| Dec 31, 2025 | -50.41 Mn |
| Sep 30, 2025 | -35.96 Mn |
| Jun 30, 2025 | -40.73 Mn |
| Mar 31, 2025 | -48.44 Mn |
| Dec 31, 2024 | -81.68 Mn |
| Sep 30, 2024 | -41.67 Mn |
| Jun 30, 2024 | -80.28 Mn |
| Mar 31, 2024 | -53.47 Mn |
| Dec 31, 2023 | -95.43 Mn |
| Sep 30, 2023 | -69.15 Mn |
| Jun 30, 2023 | -120.90 Mn |
| Mar 31, 2023 | -49.14 Mn |
| Dec 31, 2022 | -61.77 Mn |
| Sep 30, 2022 | -161.19 Mn |
| Jun 30, 2022 | -137.93 Mn |
| Mar 31, 2022 | -82.39 Mn |
| Dec 31, 2021 | -211.83 Mn |
| Sep 30, 2021 | -96.41 Mn |
| Jun 30, 2021 | -163.32 Mn |